Jubilant Life Sciences has informed about proposal to issue unsecured bonds by the company’s wholly-owned subsidiary Jubilant Pharma (a company incorporated under the laws of Singapore), outside India, under Regulation S of the US Securities Act of 1933, as amended.
The above information is a part of company’s filings submitted to BSE.